Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
European Journal of Pharmacology|March 2, 2020
Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient miceByambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology|August 17, 2015
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient miceHotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology|November 24, 2019
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic miceArief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
Journal of Atherosclerosis and Thrombosis|September 4, 2020
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient MiceByambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology|March 29, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient miceHotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 27, 2004
Long-term beneficial effect of infarct-related artery patency in acute anterior myocardial infarction in patients with poor myocardial viability in the region-at-riskDaiju Fukuda, Minoru Yoshiyama, Kenei Shimada, et al.
Plos One|November 8, 2014
MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanismMasayoshi Ishida, Michio Shimabukuro, Shusuke Yagi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2024
Utility and optimal dose of nicorandil for physiological assessment of the femoropopliteal arteryNaoki Yoshioka, Takenobu Shimada, Yoshihiro Iwasaki, et al.
International Heart Journal|November 19, 2019
Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient MiceKunduziayi Aini, Daiju Fukuda, Kimie Tanaka, et al.
Diabetes Research and Clinical Practice|August 28, 2004
Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery diseaseKenei Shimada, Takahiko Kawarabayashi, Atsushi Tanaka, et al.
Pageof 24